| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.7M | — | -8.1% |
| Cost of Revenue | $4.8M | — | -11.3% |
| R&D Expense | $3.1M | — | -19.8% |
| SG&A Expense | $6.8M | — | -6.0% |
| Operating Income | $3.1M | — | +134.5% |
| Interest Expense | $553K | — | -16.2% |
| Pre-tax Income | $2.5M | — | +126.3% |
| Income Tax | $956K | — | +858.7% |
| Net Income | $1.5M | — | +116.4% |
| EPS (Basic) | $0.04 | — | +119.0% |
| EPS (Diluted) | $0.04 | — | +119.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.0M | +3.6% | +13.4% |
| Accounts Receivable | $19.1M | +6.2% | -18.5% |
| Current Assets | $25.4M | +3.9% | -15.1% |
| Total Assets | $192.0M | +2.0% | -9.5% |
| Current Liabilities | $57.2M | +3.8% | -9.9% |
| Long-term Debt | $33.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.4M | — | +274.2% |
| Capital Expenditures | $1.6M | — | -23.7% |
| Investing Cash Flow | -$6.6M | — | -207.1% |
| Financing Cash Flow | -$1.7M | — | -47.4% |
| Free Cash Flow | $6.8M | — | +7585.2% |
| +0.0% |
| Total Liabilities | $99.5M | +6.1% | -8.0% |
| Stockholders' Equity | $92.5M | -2.1% | -11.0% |